Garajová, I.; Gelsomino, F.; Salati, M.; Mingozzi, A.; Peroni, M.; De Lorenzo, S.; Granito, A.; Tovoli, F.; Leonardi, F.
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? Life 2023, 13, 2170.
https://doi.org/10.3390/life13112170
AMA Style
Garajová I, Gelsomino F, Salati M, Mingozzi A, Peroni M, De Lorenzo S, Granito A, Tovoli F, Leonardi F.
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? Life. 2023; 13(11):2170.
https://doi.org/10.3390/life13112170
Chicago/Turabian Style
Garajová, Ingrid, Fabio Gelsomino, Massimiliano Salati, Anna Mingozzi, Marianna Peroni, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli, and Francesco Leonardi.
2023. "Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?" Life 13, no. 11: 2170.
https://doi.org/10.3390/life13112170
APA Style
Garajová, I., Gelsomino, F., Salati, M., Mingozzi, A., Peroni, M., De Lorenzo, S., Granito, A., Tovoli, F., & Leonardi, F.
(2023). Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? Life, 13(11), 2170.
https://doi.org/10.3390/life13112170
